当前位置: X-MOL 学术J. Orthop. Surg. Res. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
The efficacy of Enhanced Recovery after Surgery (ERAS) for elderly patients with intertrochanteric fractures who received surgery: study protocol for a randomized, blinded, controlled trial
Journal of Orthopaedic Surgery and Research ( IF 2.6 ) Pub Date : 2020-03-05 , DOI: 10.1186/s13018-020-01586-w
Mengchen Yin , Yinjie Yan , Zhaoxiang Fan , Niankang Fang , Hongbo Wan , Wen Mo , Xuequn Wu

Intertrochanteric fracture (ITF) is increasing with the rapid increase in the aging population, often causes a high mortality rate in old patients and increases the economic burden of the family and society. ERAS (Enhanced Recovery after Surgery) is a powerful guarantee for patients to accelerate their recovery after surgery. TCM (traditional Chinese medicine) promotes repair of injured tissues and eliminates traumatic aseptic inflammation. Therefore, this prospective randomized controlled clinical trial aims to evaluate the clinical effect of the evidence-based ERAS pathway of integrating TCM with western medicine on perioperative outcomes in ITF patients undergoing intramedullary fixation and provide reliable evidence-based data for applying the program to clinical practice. We will conduct a prospective randomized, blinded, controlled trial to compare the effectiveness of ERAS care pathway with traditional care pathway and to investigate whether the ERAS care pathway can improve the perioperative outcome in ITF patients undergoing intramedullary fixation. A total of 60 patients with ITF will be enrolled and treated with the two care pathway, respectively. Length of stay, economic indicators, Harris score, VAS score, time to get out of bed, 30-day readmission rates, postoperative transfusion rates, discharge to home, and mortality will be evaluated. Any signs of acute adverse reactions will be recorded at each visit during treatment. Although an evidence-based process using the best available literature and Delphi expert-opinion method has been used to establish an ERAS pathway of integrating TCM with western medicine, there is a lack of consensus about its effectiveness. This trial will provide convincing evidence about the effect of ERAS pathway. Registered on 12 October 2019. Trial number is ChiCTR1900026487.

中文翻译:

老年股骨转子间骨折患者手术后增强康复的疗效:一项随机,盲法,对照试验的研究方案

股骨粗隆间骨折(ITF)随着人口老龄化的迅速增加而增加,常常导致老年患者的高死亡率,并增加家庭和社会的经济负担。ERAS(手术后增强恢复)是患者加速手术后恢复的有力保证。中医促进受损组织的修复,消除创伤性无菌性炎症。因此,该前瞻性随机对照临床试验旨在评估中西医结合的循证ERAS途径对接受髓内固定的ITF患者围手术期结局的临床效果,并提供可靠的循证数据以将该程序应用于临床实践。我们将进行前瞻性随机,盲目,一项对照试验,将ERAS护理途径与传统护理途径的有效性进行比较,并调查ERAS护理途径是否可以改善接受髓内固定的ITF患者的围手术期结局。共有60名ITF患者将通过两种护理途径入组并接受治疗。评估住院时间,经济指标,Harris评分,VAS评分,起床时间,30天再入院率,术后输血率,出院率和死亡率。在治疗期间的每次就诊中都将记录任何急性不良反应的迹象。尽管使用了现有最佳文献和Delphi专家意见法进行的循证过程已建立了将中医药与西药结合的ERAS途径,对其有效性缺乏共识。该试验将提供有关ERAS途径作用的令人信服的证据。于2019年10月12日注册。注册号为ChiCTR1900026487。
更新日期:2020-03-06
down
wechat
bug